Product
TDM-180935
2 clinical trials
2 indications
Indication
Atopic DermatitisIndication
HealthyClinical trial
A Randomized, Vehicle-Controlled, Parallel Group Study of Topical TDM-180935 to Evaluate the Preliminary Efficacy, Safety, Tolerability, and Pharmacokinetics in Atopic Dermatitis PatientsStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
A Randomized, Double-blind, Vehicle-controlled, Parallel Group, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TDM-180935 Following Topical Administration in Healthy Male SubjectsStatus: Completed, Estimated PCD: 2023-08-18